Abiraterone Impurity 17 | CAS 114611-53-9 - Request Quote
Abiraterone Impurity 17
| SZ CAT No: | SZ-A006078 |
| CAS No | 114611-53-9 |
| Mol.F. | C21H29IO2 |
| Mol.Wt. | 440.4 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Abiraterone Impurity 17 is chemically 17-Iodoandrosta-5,16-dien-3beta-ol 3-Acetate. Abiraterone Impurity 17 is supplied with detailed characterization data compliant with regulatory guideline. Abiraterone Impurity 17 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Abiraterone Acetate.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 114611-53-9
Purchase 114611-53-9
Order 114611-53-9
Enquire 114611-53-9
price of 114611-53-9
114611-53-9 Supplier
114611-53-9 Manufacturer
114611-53-9 Exporter
buy high quality Abiraterone Impurity 17
Purchase Abiraterone Impurity 17
Abiraterone Impurity 17 suppliers
Abiraterone Impurity 17 manufacturers
Abiraterone Impurity 17 price
Order Abiraterone Impurity 17
Enquire Abiraterone Impurity 17
Abiraterone Impurity 17 cost
Abiraterone Impurity 17 Supplier
Abiraterone Impurity 17 Distributor
Abiraterone Impurity 17 for Method Validation
Abiraterone Acetate Reference Standard
Abiraterone Impurity 17 for ANDA Filing
Abiraterone Impurity 17 for Forced Degradation Studies
Abiraterone Impurity 17 Identification Standards
Abiraterone Impurity 17 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.